OBJECTIVE: To determine the incidence of pancreatitis and pancreatic cancer in the SAVOR-TIMI 53 trial.RESEARCH DESIGN AND METHODS A total of 16,492 type 2 diabetic patients 40 years old with established cardiovascular (CV) disease or CV risk factors were randomized to saxagliptin or placebo and followed for 2.1 years.
READ FULL ARTICLE
From Diabetesjournals